|Bid||11,650.00 x 200|
|Ask||11,660.00 x 34100|
|Day's Range||11,640.00 - 11,850.00|
|52 Week Range||99.40 - 11,850.00|
|PE Ratio (TTM)||149,358.97|
|Dividend & Yield||1.36 (4.67%)|
|1y Target Est||N/A|
A treatment AstraZeneca hoped would replace chemotherapy for some lung cancer patients was no better at preventing the disease from getting worse in clinical tests, dealing a major blow for one of the ...
Philosopher Blaise Pascal never faced proof he was wrong to believe in God. AstraZeneca's Pascal Soriot has discovered his faith in the Mystic cancer drug trial really was misplaced. A failure of a key ...
Regardless of how the debate over repealing the Affordable Care Act plays out, there are plenty of reason to like health care as a long-term investment, says Jeff Reeves.